Surgery Partners, Inc.
SGRY
$24.05
-$0.11-0.46%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -546.94% | -182.01% | 50.20% | 95.73% | 80.40% |
Total Depreciation and Amortization | 73.70% | 42.62% | 0.00% | 5.07% | -3.02% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 27.38% | 113.57% | 5.16% | 8.51% | -4.39% |
Change in Net Operating Assets | -229.36% | 30.65% | -430.70% | 26.59% | 159.56% |
Cash from Operations | -37.67% | 58.93% | -45.37% | 769.44% | 252.19% |
Capital Expenditure | -6.88% | -4.26% | 13.58% | 12.78% | -9.25% |
Sale of Property, Plant, and Equipment | 100.00% | -100.00% | -81.25% | -100.00% | -- |
Cash Acquisitions | -401.89% | -7,400.00% | -34.15% | 51.10% | 31.17% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -154.55% | 88.14% | 34.31% | -607.14% | 96.25% |
Cash from Investing | -93.75% | -242.84% | -17.54% | 19.53% | 52.85% |
Total Debt Issued | 81.27% | 10,304.72% | 1,110.69% | 324.49% | 139.43% |
Total Debt Repaid | -78.57% | -5,371.79% | -655.97% | 10.31% | -56.85% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -7.96% | -35.68% | 1.46% | 31.75% | 2.33% |
Cash from Financing | 64.22% | 486.94% | 176.94% | -123.10% | 57.50% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -85.84% | 141.56% | 71.39% | -131.30% | 180.72% |